592 related articles for article (PubMed ID: 15735310)
1. Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing.
Offergeld R; Faensen D; Ritter S; Hamouda O
Euro Surveill; 2005 Feb; 10(2):8-11. PubMed ID: 15735310
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus, hepatitis C and hepatitis B infections among blood donors in Germany 2000-2002: risk of virus transmission and the impact of nucleic acid amplification testing.
Offergeld R; Faensen D; Ritter S; Hamouda O
Euro Surveill; 2005 Feb; 10(2):13-14. PubMed ID: 29183561
[TBL] [Abstract][Full Text] [Related]
3. Experience of German Red Cross blood donor services with nucleic acid testing: results of screening more than 30 million blood donations for human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus.
Hourfar MK; Jork C; Schottstedt V; Weber-Schehl M; Brixner V; Busch MP; Geusendam G; Gubbe K; Mahnhardt C; Mayr-Wohlfart U; Pichl L; Roth WK; Schmidt M; Seifried E; Wright DJ;
Transfusion; 2008 Aug; 48(8):1558-66. PubMed ID: 18466173
[TBL] [Abstract][Full Text] [Related]
4. Residual risk of transfusion-transmitted viral infections in Spain, 1997-2002, and impact of nucleic acid testing.
Alvarez do Barrio M; González Díez R; Hernández Sánchez JM; Oyonarte Gómez S
Euro Surveill; 2005 Feb; 10(2):20-2. PubMed ID: 15735311
[TBL] [Abstract][Full Text] [Related]
5. Impact of nucleic acid amplification technology (NAT) in Italy in the three years following implementation (2001-2003).
Velati C; Fomiatti L; Baruffi L; Romanò L; Zanetti A;
Euro Surveill; 2005 Feb; 10(2):12-4. PubMed ID: 15735315
[TBL] [Abstract][Full Text] [Related]
6. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
[TBL] [Abstract][Full Text] [Related]
7. Incidence of viral markers and evaluation of the estimated risk in the Swiss blood donor population from 1996 to 2003.
Niederhauser C; Schneider P; Fopp M; Ruefer A; Lévy G
Euro Surveill; 2005 Feb; 10(2):14-6. PubMed ID: 15735314
[TBL] [Abstract][Full Text] [Related]
8. Estimates of the frequency of HBV, HCV, and HIV infectious donations entering the blood supply in the United Kingdom, 1996 to 2003.
Soldan K; Davison K; Dow B
Euro Surveill; 2005 Feb; 10(2):17-9. PubMed ID: 15735312
[TBL] [Abstract][Full Text] [Related]
9. Trends in prevalence, incidence, and residual risk of major transfusion-transmissible viral infections in United Arab Emirates blood donors: impact of individual-donation nucleic acid testing, 2004 through 2009.
Al Shaer L; AbdulRahman M; John TJ; AlHashimi A
Transfusion; 2012 Nov; 52(11):2300-9. PubMed ID: 22691239
[TBL] [Abstract][Full Text] [Related]
10. [Trends in residual risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2002 and impact of viral genome screening (Nucleic Acid Testing)].
Pillonel J; Laperche S; ; ;
Transfus Clin Biol; 2004 Apr; 11(2):81-6. PubMed ID: 15120104
[TBL] [Abstract][Full Text] [Related]
11. [Epidemiological data on infections among blood donors in Germany 2007].
Offergeld R; Ritter S; Quabeck L; Hamouda O
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2010 Nov; 53(11):1188-96. PubMed ID: 20976426
[TBL] [Abstract][Full Text] [Related]
12. Impact of nucleic acid testing for hepatitis B virus, hepatitis C virus, and human immunodeficiency virus on the safety of blood supply in Italy: a 6-year survey.
Velati C; Romanò L; Fomiatti L; Baruffi L; Zanetti AR;
Transfusion; 2008 Oct; 48(10):2205-13. PubMed ID: 18631163
[TBL] [Abstract][Full Text] [Related]
13. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.
Chiavetta JA; Escobar M; Newman A; He Y; Driezen P; Deeks S; Hone DE; O'Brien SF; Sher G
CMAJ; 2003 Oct; 169(8):767-73. PubMed ID: 14557314
[TBL] [Abstract][Full Text] [Related]
14. Trends in risk of transfusion-transmitted viral infections (HIV, HCV, HBV) in France between 1992 and 2003 and impact of nucleic acid testing (NAT).
Pillonel J; Laperche S;
Euro Surveill; 2005 Feb; 10(2):5-8. PubMed ID: 15735313
[TBL] [Abstract][Full Text] [Related]
15. Residual risk of transfusion-transmitted human immunodeficiency virus, hepatitis C virus, and hepatitis B virus infections in Italy.
Gonzalez M; Règine V; Piccinini V; Vulcano F; Giampaolo A; Hassan HJ
Transfusion; 2005 Oct; 45(10):1670-5. PubMed ID: 16181219
[TBL] [Abstract][Full Text] [Related]
16. Current incidence and estimated residual risk of transfusion-transmitted infections in donations made to Canadian Blood Services.
O'Brien SF; Yi QL; Fan W; Scalia V; Kleinman SH; Vamvakas EC
Transfusion; 2007 Feb; 47(2):316-25. PubMed ID: 17302779
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B virus testing by minipool nucleic acid testing: does it improve blood safety?
Stramer SL; Notari EP; Krysztof DE; Dodd RY
Transfusion; 2013 Oct; 53(10 Pt 2):2449-58. PubMed ID: 23607261
[TBL] [Abstract][Full Text] [Related]
18. Mathematic modeling of the risk of HBV, HCV, and HIV transmission by window-phase donations not detected by NAT.
Weusten JJ; van Drimmelen HA; Lelie PN
Transfusion; 2002 May; 42(5):537-48. PubMed ID: 12084161
[TBL] [Abstract][Full Text] [Related]
19. Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program.
Satake M; Taira R; Yugi H; Hino S; Kanemitsu K; Ikeda H; Tadokoro K
Transfusion; 2007 Jul; 47(7):1197-205. PubMed ID: 17581154
[TBL] [Abstract][Full Text] [Related]
20. A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.
Li L; Chen PJ; Chen MH; Chak KF; Lin KS; Tsai SJ
Transfusion; 2008 Jun; 48(6):1198-206. PubMed ID: 18422856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
